Proximity Extension Assay
The protein biomarker panels developed by Olink Proteomics is a unique technology (Proximity Extension Assay) enabling high-throughput, multiplex immunoassay-qPCR that measure 92 proteins across 96 samples simultaneously using only one microliter of serum, plasma, or equivalent amounts of almost any other type of biological sample. The innovative dual recognition, DNA-coupled methodology provides exceptional readout specificity, enabling high multiplex, rapid throughput protein biomarker analysis without compromising on data quality assay robustness.
The 1165 immuno-PCR-assays developed are divided into 15 disease-focused panels of 92 proteins. Samples may be analysed against one or more panels using only 1µl of sample per panel.
See the full list of proteins in all panels here:
The content of each panel can be found here, including proteins mapped to disease area and biological process:
The main steps involved in each protein quantification assay are outlined to the left. A pair of oligonucleotide-labelled antibodies, Proseek probes, are allowed to pair-wise bind to the target protein present in the sample in a homogeneous assay, with no need for washing. When the two Proseek probes are in close proximity, a new PCR target sequence is formed by a proximity-dependent DNA polymerization event. The resulting sequence is subsequently detected and quantified using the Fluidigm Biomark HD real-time PCR system that allows for the analysis of 96 samples against 96 assays in a nanoliter scale within 3 hours.
Real-Time qPCR Technology
BioXpedia provides sample preparation and high-quality extraction of DNA, RNA, and protein for any downstream analysis. To ensure maximum reproducibility and efficiency, automated workflow and robotic pipetting is used whenever possible.
DNA and RNA can be isolated from fresh, frozen and fixed tissue along with any biofluid sample. Additionally, we offer isolation of free-circulating nucleic acids and isolation of extracellular vesicles like exosomes from plasma, serum and other biofluid for nucleic acid and protein analysis.
The nCounter® Analysis System from NanoString Technologies offers single molecule detection, using unique fluorescent barcodes. The colour-coded barcodes enable direct, digital detection of hundreds (≤800) of individual target molecules in a single assay. This will allow you to see the relationship between, DNA, RNA, and protein in one single sample and compare genotyping with gene and protein expression. NanoString can detect target molecules as small as 100 base pairs and only requires a limited input amount of 100ng. This enables multiplex gene expression profiling with single cell worth of input.
meso scale – msd
Meso Scale Discovery
The MSD technology offers absolute quantitation of protein markers using electrochemiluminescence immunoassays providing high sensitivity and multiplex functionality. The platform is highly flexible offering ultra-sensitive and thoroughly validated assay panels and customized assay combinations of your own choice. The assays are provided as single analyte assays or multiplex assays up to 10-plex in each well.
Available assays cover a wide range of biological applications, with more than 500 assays provided in panels, custom panels or reagent kits to build your own assay. The assay panels are focused on measuring proteins associated to for example inflammation, oncology, neurodegeneration, immunology, intracellular signaling, cardiovascular disease and metabolism. Assays are available for different species and compatible with an array of complex sample types e.g. serum, plasma, supernatants, cell lysates, CSF, urine, blood spots, tears, synovial fluid, tissue extracts etc.
MSD assays are based on a proprietary technology combining electrochemiluminescence and MULTI‑ARRAY technology for detection of proteins in biological samples. Analytes of interest are detected using sulfo-tag-conjugated reporter molecules and the Meso Scale instrument. Electrochemiluminescence detection offers a unique combination of sensitivity, accuracy and dynamic range for absolute quantitation of single proteins or protein profiles.
V-PLEX assays are designed and produced to maximize reproducible performance, consistency and reliability in results and confidence in data. The assays and panels are fully validated in multiple matrices according to fit-for-purpose principles. Assays are organized into panels by species, analytical compatibility, clinical range and expected use to ensure optimal and consistent performance and lot-to-lot consistency is guaranteed to support long-term studies.
Build your own assays
The U-PLEX is an open platform that offers full flexibility to design and develop your own single analyte and multiplex assays targeted the proteins studied in your project. More than 160 assays are available on the U-PLEX platform, these can be used alone or combined in multiplex with your own assays.
In U-PLEX assays biotinylated capture reagents are coupled to U-PLEX linkers and bound to spots on the plate. Analytes in the sample bind to the capture reagents and detection antibodies conjugated with electrochemiluminescence labels bind to the analytes to complete the sandwich assay.
Finally, R-PLEX antibody sets can also be used for development of multiplex or single analyte immunoassays. Each R-PLEX antibody set contains a biotinylated capture antibody, sulfo-tag labeled detection antibody and a calibrator.